{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:50:10Z","timestamp":1791388210301,"version":"4.3.3"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2100800"],"award-info":[{"award-number":["2021YFC2100800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21978273"],"award-info":[{"award-number":["21978273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22378360"],"award-info":[{"award-number":["22378360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2021C03085"],"award-info":[{"award-number":["2021C03085"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116786","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T03:47:08Z","timestamp":1716781628000},"page":"116786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comprehensive safety evaluation of a novel multitargeting compound XYY-CP1106: A candidate for Alzheimer's disease"],"prefix":"10.1016","volume":"176","author":[{"given":"Miaoliang","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-146X","authenticated-orcid":false,"given":"Changjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-6957","authenticated-orcid":false,"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-9948","authenticated-orcid":false,"given":"Yuanyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.stem.2023.02.006","article-title":"Activation of hypothalamic-enhanced adult-born neurons restores cognitive and affective function in Alzheimer?s disease","volume":"30","author":"Li","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopha.2024.116786_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awad163","article-title":"Comprehension of acoustically degraded speech in Alzheimer's disease and primary progressive aphasia","author":"Jiang","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2024.116786_bib3","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/brain\/awt165","article-title":"Comparative semantic profiles in semantic dementia and Alzheimer's disease","volume":"136","author":"Libon","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2024.116786_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115817","article-title":"Targeting protein kinases for the treatment of Alzheimer's disease: recent progress and future perspectives","volume":"261","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101787","article-title":"AChE as a spark in the Alzheimer's blaze-Antagonizing effect of a cyclized variant","volume":"83","author":"Behl","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.phrs.2003.12.027","article-title":"Acetylcholinesterase inhibitors: novel activities of old molecules","volume":"50","author":"Racchi","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2024.116786_bib8","article-title":"Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry","author":"Hanson","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2024.116786_bib9","first-page":"I6217","article-title":"Cognitive symptoms of Alzheimer's disease: clinical management and prevention","volume":"367","author":"Joe","year":"2019","journal-title":"BMJ [Br. Med. J."},{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: First approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2024.116786_bib11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3390\/ph15121560","article-title":"Current pharmacotherapy and multi-target approaches for Alzheimer's disease","volume":"15","author":"Cheong","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.biopha.2024.116786_bib12","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.3390\/ijms23116085","article-title":"Effects of linkers and substitutions on multitarget directed ligands for Alzheimer's diseases: emerging paradigms and strategies","volume":"23","author":"Pravin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"32","key":"10.1016\/j.biopha.2024.116786_bib13","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.2174\/092986711797535245","article-title":"Multi-target-directed ligands in Alzheimer's disease treatment","volume":"18","author":"Bajda","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.116786_bib14","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/med.21699","article-title":"From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacology","volume":"41","author":"Albertini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2024.116786_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2021.106735","article-title":"A mechanistic survey of Alzheimer's disease","volume":"281","author":"Tang","year":"2022","journal-title":"Biophys. Chem."},{"issue":"29","key":"10.1016\/j.biopha.2024.116786_bib16","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.2174\/0929867325666180111101843","article-title":"Multi-target directed drugs as a modern approach for drug design towards Alzheimer's disease: An update","volume":"25","author":"Silva","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.116786_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/1385272823666191021124443","article-title":"Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases","volume":"18","author":"Gontijo","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2024.116786_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113576","article-title":"Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes","volume":"154","author":"Dai","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116786_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103009","article-title":"Metal ion mediated aggregation of Alzheimer's disease peptides and proteins in solutions and at surfaces","volume":"320","author":"Feng","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2024.116786_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126158","article-title":"Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification","volume":"251","author":"Lv","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.116786_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114464","article-title":"Alzheimer's disease: updated multi-targets therapeutics are in clinical and in progress","volume":"238","author":"Sang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102033","article-title":"The neurobiology and therapeutic potential of multi-targeting \u03b2-secretase, glycogen synthase kinase 3\u03b2 and acetylcholinesterase in Alzheimer's disease","volume":"90","author":"Fronza","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"7-8","key":"10.1016\/j.biopha.2024.116786_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-023-01848-y","article-title":"Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues","volume":"28","author":"Kumari","year":"2023","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/1570159X14666160119094820","article-title":"AChE inhibition-based multi-target-directed ligands, a novel pharmacological approach for the symptomatic and disease-modifying therapy of Alzheimer's disease","volume":"14","author":"Wang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116786_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1389450123666220926143920","article-title":"Study on multi-target synergistic treatment of Alzheimer's disease based on metal chelators","volume":"24","author":"Yang","year":"2023","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/antiox11040692","article-title":"Iron dysregulation in mitochondrial dysfunction and Alzheimer's disease","volume":"11","author":"Onukwufor","year":"2022","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.biopha.2024.116786_bib28","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2024.116786_bib29","article-title":"Porphyromonas gingivalis and the pathogenesis of Alzheimer's disease","author":"Liu","year":"2023","journal-title":"Crit. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/antiox12040918","article-title":"The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases","volume":"12","author":"Lee","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2024.116786_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-017-0279-1","article-title":"Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with \u03b3-secretase and regulates neuronal amyloid \u03b2-peptide levels","volume":"9","author":"Schedin-Weiss","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.biopha.2024.116786_bib32","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ejmech.2016.11.016","article-title":"Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B","volume":"125","author":"Van der Walt","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116786_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.biopha.2024.116786_bib34","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116786_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2024.116786_bib36","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00702-018-1942-9","article-title":"Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases","volume":"125","author":"Youdim","year":"2018","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.biopha.2024.116786_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00702-011-0597-6","article-title":"Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim","volume":"118","author":"Weinreb","year":"2011","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116786_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/antiox12020214","article-title":"On the chemical and biological characteristics of multifunctional compounds for the treatment of Parkinson's disease","volume":"12","author":"Garc\u00eda-Beltr\u00e1n","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2024.116786_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104564","article-title":"Design, synthesis and biological evaluation of potential anti-AD hybrids with monoamine oxidase B inhibitory and iron-chelating effects","volume":"108","author":"Guo","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejmech.2019.07.031","article-title":"Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease","volume":"180","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106817","article-title":"Exploration of the novel phthalimide-hydroxypyridinone derivatives as multifunctional drug candidates against Alzheimer's disease","volume":"141","author":"Zhu","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116786_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.29327","article-title":"The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat","volume":"67","author":"Yip","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116786_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/07391102.2021.2004232","article-title":"Computational design of new tacrine analogs: an in silico prediction of their cholinesterase inhibitory, antioxidant, and hepatotoxic activities","volume":"41","author":"Djafarou","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.biopha.2024.116786_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/tcr.202000107","article-title":"Tacrines as therapeutic agents for Alzheimer's disease. V. recent developments","volume":"21","author":"Bautista-Aguilera","year":"2021","journal-title":"Chem. Rec."},{"key":"10.1016\/j.biopha.2024.116786_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107134","article-title":"Efficacy and safety of donepezil for mild cognitive impairment: A systematic review and meta-analysis","volume":"213","author":"Zhang","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"6","key":"10.1016\/j.biopha.2024.116786_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40264-014-0161-z","article-title":"Cardiovascular effects of drugs used to treat Alzheimer's disease","volume":"37","author":"Howes","year":"2014","journal-title":"Drug Saf."},{"issue":"8","key":"10.1016\/j.biopha.2024.116786_bib47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-148-8-200804150-00023","article-title":"Memantine-induced hepatitis with cholestasis in a very elderly patient","volume":"148","author":"Ferrara","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.biopha.2024.116786_bib48","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acs.jmedchem.7b01417","article-title":"Design, synthesis, and evaluation of orally bioavailable quinoline-indole derivatives as innovative multitarget-directed ligands: promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer's disease","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112217","article-title":"Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation","volume":"193","author":"Fan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmech.2019.02.053","article-title":"Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease","volume":"168","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111958","article-title":"Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease","volume":"187","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112381","article-title":"Aqueous extract of Forsythia viridissima fruits: acute oral toxicity and genotoxicity studies","volume":"249","author":"Shin","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116786_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3980972","article-title":"Safety assessment and comparison of sodium selenite and bioselenium obtained from Yeast in mice","volume":"2017","author":"Wang","year":"2017","journal-title":"BioMed. Res. Int."},{"issue":"7","key":"10.1016\/j.biopha.2024.116786_bib54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41575-019-0134-x","article-title":"Spatial heterogeneity in the mammalian liver","volume":"16","author":"Ben-Moshe","year":"2019","journal-title":"Nat. Rev. Gastro. Hepat."},{"key":"10.1016\/j.biopha.2024.116786_bib55","doi-asserted-by":"crossref","unstructured":"OECD, Test No. 420: Acute Oral Toxicity - Fixed Dose Procedure, (2002). https:\/\/doi.org\/10.1787\/9789264070943-en.","DOI":"10.1787\/9789264070943-en"},{"key":"10.1016\/j.biopha.2024.116786_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103844","article-title":"Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease","volume":"99","author":"Liao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116786_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116786_bib58","first-page":"29","article-title":"The Ames Salmonella\/microsome mutagenicity assay","volume":"455","author":"Mortelmans","year":"2000","journal-title":"Mutat. Res-Fund. Mol. M."},{"issue":"4","key":"10.1016\/j.biopha.2024.116786_bib59","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/01480545.2011.627865","article-title":"Mutagenicity and clastogenicity evaluation of tacrine by Ames and micronucleus assays","volume":"35","author":"Mulla","year":"2012","journal-title":"Drug Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116786_bib60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1383-5718(97)00096-X","article-title":"Genetic toxicity studies of 1,2,3,4-tetrahydro-9-acridinamine (tacrine)","volume":"393","author":"Zeiger","year":"1997","journal-title":"Mutat. Res-Gen. Toxicol. Environ."},{"issue":"1","key":"10.1016\/j.biopha.2024.116786_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-1110(90)90030-F","article-title":"The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program","volume":"239","author":"Mavournin","year":"1990","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2024.116786_bib62","unstructured":"OECD, 2016, Test No. 473: In Vitro Mammalian Chromosomal Aberration Test, (2016). https:\/\/doi.org\/10.1787\/9789264264649-en.."},{"key":"10.1016\/j.biopha.2024.116786_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.607026","article-title":"Toxicity evaluation of the naphthalen-2-yl 3,5-dinitrobenzoate: A drug candidate for Alzheimer disease","volume":"12","author":"Anwar","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116786_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yrtph.2019.04.001","article-title":"Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats","volume":"105","author":"Li","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116786_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/00002093-199424000-00005","article-title":"Tacrine and transaminases","volume":"8","author":"Watkins","year":"1994","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"9843","key":"10.1016\/j.biopha.2024.116786_bib66","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2024.116786_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.biopha.2024.116786_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44142-2","article-title":"Safety comparisons among monoamine oxidase inhibitors against Parkinson's disease using FDA adverse event reporting system","volume":"13","author":"Asano","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2024.116786_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2005.00294.x","article-title":"The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients","volume":"111","author":"Stryjer","year":"2005","journal-title":"Acta Neurol. Scand."},{"issue":"10","key":"10.1016\/j.biopha.2024.116786_bib70","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/mds.21048","article-title":"Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline","volume":"21","author":"Demarcaida","year":"2006","journal-title":"Mov. Disord."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400670X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400670X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:57:44Z","timestamp":1781650664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222400670X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":70,"alternative-id":["S075333222400670X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116786","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive safety evaluation of a novel multitargeting compound XYY-CP1106: A candidate for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116786"}}